TD Asset Management »

Apogee Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.8M 148k 66.45
2023-12-31 $2.8M 101k 27.94
2023-09-30 $677k 32k 21.30